← FDA DRUG APPROVALS

FDA NDA · NDA017551

PERCHLORACAP

Sponsor: MALLINCKRODT

APPLICATION
NDA017551
TYPE
NDA
ORIGINAL APPROVAL
1974-11-21
LATEST ACTION
1994-06-30
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

PERCHLORACAPDiscontinued
POTASSIUM PERCHLORATE 200MG · CAPSULE · ORAL

Approval history

1994-06-30Manufacturing (CMC) · Supplement 5 · standardAP
1990-01-19Labeling · Supplement 4AP
1983-07-26Labeling · Supplement 3 · standardAP
1977-07-27Manufacturing (CMC) · Supplement 2 · standardAP
1976-08-14Manufacturing (CMC) · Supplement 1 · standardAP
1974-11-21Type 1 - New Molecular Entity · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →